Therefore, modulation of SAMHD1 activity by drugs or potentially through targeting of SAMHD1 for proteasomal degradation by the lentiviral accessory protein Vpx has been proposed as a strategy for improving anti-cancer and anti-HIV therapies29,34,37. This evidence concerns the gene SAMHD1 and cancer.